Nina Gentile, MD, Professor of Emergency Medicine at the Lewis Katz School of Medicine at Temple University, presented the details and results of the I-SPOT trial at the International Stroke Conference in February. The American Heart Association included a write-up in its Professional Heart Daily newsletter, and Dr. Gentile participated in a video interview on the subject as well. The Insights on Selected Procoagulation Markers and Outcomes in Stroke (I-SPOT) trial was an ancillary study related to the Stroke Hyperglycemia Insulin Network Effort (SHINE) clinical trial. The goal was to study the effects of glucose levels and hyperglycemia control on blood coagulation markers and their relationships to functional neurological outcomes in patients with acute ischemic stroke. Dr. Gentile was the principal investigator of I-SPOT.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
310 Temple Health Physicians Named ‘Top Doctors’ by Philadelphia Magazine
Posted April 22, 2024These Temple Health physicians practice at Main Campus, Fox Chase, Jeanes Campus, Episcopal Campus, Chestnut Hill Hospital, Temple Physicians, Inc. and Fair Hill Community Physicians.
Read MoreCompassion in Critical Moments: Temple Team Leads the Way in Trauma-Informed Care
Posted April 19, 2024By the time a patient with a firearm-related injury arrives at Temple Health, they’ve already experienced an extraordinary amount of trauma. Our job is not only to care for that patient, but to ensure that their time here is as safe and supportive as possible.
Read More